Andrew C. Orth
2021
In 2021, Andrew C. Orth earned a total compensation of $9M as Chief Commercial Officer at Krystal Biotech.
Compensation breakdown
| Bonus | $130,508 |
|---|---|
| Option Awards | $8,579,300 |
| Salary | $269,091 |
| Other | $9,917 |
| Total | $9,003,059 |
Orth received $8.6M in option awards, accounting for 95% of the total pay in 2021.
Orth also received $130.5K in bonus, $269.1K in salary and $9.9K in other compensation.
Rankings
In 2021, Andrew C. Orth's compensation ranked 1,225th out of 12,397 executives tracked by ExecPay. In other words, Orth earned more than 90.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,225 out of 12,397 | 90th |
Division Manufacturing | 435 out of 5,492 | 92nd |
Major group Chemicals And Allied Products | 156 out of 2,367 | 93rd |
Industry group Drugs | 129 out of 2,090 | 94th |
Industry Biological Products, Except Diagnostic Substances | 37 out of 452 | 92nd |
Source: SEC filing on April 7, 2022.
Orth's colleagues
We found three more compensation records of executives who worked with Andrew C. Orth at Krystal Biotech in 2021.